# Efficacy and Safety of Polyoxidonium, Nasal and Sublingual Spray, 6 mg/ml in Children Aged 1-12 Years With ARI

> **NCT03840135** · PHASE3 · COMPLETED · sponsor: **NPO Petrovax** · enrollment: 172 (actual)

## Conditions studied

- Acute Respiratory Infection

## Interventions

- **DRUG:** Polyoxidonium 6 mg/ml
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03840135
- **Lead sponsor:** NPO Petrovax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-07
- **Primary completion:** 2019-02-26
- **Final completion:** 2019-12-10
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2020-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03840135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03840135, "Efficacy and Safety of Polyoxidonium, Nasal and Sublingual Spray, 6 mg/ml in Children Aged 1-12 Years With ARI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03840135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*